Delivery Order SPE2DR25D1103-SPE2DR26FF119
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,193.97 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 26, 2026, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mL. This is a firm fixed-price, non-set-aside contract with performance at the company's Conshohocken, Pennsylvania facility and an ultimate completion date of January 27, 2026. The award represents a task order issued under AmerisourceBergen's broader pharmaceutical supply relationship with the federal...
- The Defense Logistics Agency (DLA) awarded a $62,044.86 delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 7, 2026, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mL, with an ultimate completion date of January 8, 2026. The contract was competitively awarded with no set-aside designation and utilizes firm fixed-price pricing. Performance will take place at the awardee's corporate office in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a subsidiary of...
- The Defense Logistics Agency awarded a delivery order valued at $5,577.56 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 27, 2026, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mls, with an ultimate completion date of January 28, 2026. The contract employs firm fixed-price pricing and was competitively awarded with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp operates as...
- The Defense Logistics Agency awarded a $7,959.80 delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 26, 2026, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mls, with an ultimate completion date of January 27, 2026. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating full and open competition. The place of performance is located in Conshohocken, Pennsylvania, where the vendor maintains its corporate office....
- The Defense Logistics Agency awarded a delivery order valued at $5,202.52 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 27, 2026, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mls, a pharmaceutical product used in the treatment of autoimmune conditions. This is a firm fixed-price delivery order with no set-aside designation, executed on a fully competitive basis. The place of performance is located in Conshohocken, Pennsylvania, with an ultimate completion date of January 28, 2026....
- The Defense Logistics Agency awarded a $1,591.94 firm fixed-price delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 15, 2026, with an ultimate completion date of January 16, 2026. The contract covers the delivery of HUMIRA (CF) Pen 80 mg/0.8 mL, a pharmaceutical product to be performed at the company's Conshohocken, Pennsylvania location. This delivery order was competitively awarded with no set-aside designation, reflecting the vendor's established capability to...
- The Defense Logistics Agency awarded a delivery order valued at $2,300.82 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 21, 2026, for the supply of Humira Pen 40 mg/0.8 mL. This firm fixed-price delivery order, with an ultimate completion date of January 22, 2026, was issued on a non-competitive basis with no set-aside designation. The place of performance is listed as Conshohocken, Pennsylvania, which is AmerisourceBergen's corporate headquarters location. AmerisourceBergen Drug...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on January 28, 2026, by the Defense Logistics Agency for the supply of HUMIRA Pen 40 mg/0.8 mL. The contract is structured as a firm fixed-price delivery order with a ceiling value of $8,677.45 and an ultimate completion date of January 29, 2026. This award was made on a non-set-aside, fully competitive basis and is performed at the contractor's Conshohocken...
- The Defense Logistics Agency awarded a delivery order valued at $3,289.12 to AmerisourceBergen Drug Corp on January 30, 2026, for HUMIRA (CF) Pen 40 mg/0.4 mL. The contract is a firm fixed-price delivery order with an ultimate completion date of February 2, 2026, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs across military and veteran...
- The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract worth $4,098.96 to AmerisourceBergen Drug Corp's Corporate Office Division on May 20, 2024. The contract is for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS, a pharmaceutical product. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that AmerisourceBergen holds with DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a wide...
- SPE2DR25D1103Indefinite Delivery Contract
- SPE2DR25D1103-SPE2DR26FF119Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,591.96 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on February 3, 2026, for the supply of HUMIRA Pen 40 mg/0.8 mls. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of February 4, 2026, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This award was not designated for any set-aside category and was competitively awarded through open competition. This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 and extending through December 31, 2031. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the supply of a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. As a major pharmaceutical distributor and critical federal vendor, AmerisourceBergen regularly fulfills defense medical procurement requirements across multiple therapeutic domains for military treatment facilities and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 2/2/26 |